Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

IPC

Displaying 1 to 10 of 44 Posts . Displaying 10 of Posts . Page of 5 . Go To Page: . Per Page: . . . View All Sort By: .

FDA Approves ETICOVO™ (etanercept-ykro), Samsung Bioepis' Second Anti-TNF Medicine in the United States

Samsung Bioepis expands autoimmune portfolio in the United States with FDA approval of ETICOVO™ (etanercept-ykro), a biosimilar referencing ENBREL®i (etanercept). INCHEON, Korea – As of April 2019 – Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved ETICOVO™ (etanercept-ykro), a biosimilar referencing ENBREL® (etanercept), across all eligible indications for the treatment of rheumatoid arthritis, ankylosing...

Read More

AbbVie Announces Approval of SKYRIZI™ for the Treatment of Psoriasis in US, Canada, Europe and Japan

AbbVie Announces Approval of SKYRIZI™ for the Treatment of Psoriasis in US, Canada and Japan AbbVie, a research-based global biopharmaceutical company, announced on March 26, 2019 that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved SKYRIZI™, an interleukin-23 (IL-23) inhibitor, for the treatment of plaque psoriasis, generalized pustular psoriasis, erythrodermic psoriasis and psoriatic arthritis in adult patients who have an inadequate response to...

Read More

Ortho Dermatologics Receives FDA Approval of Duobriitm (Halobetasol Propionate and Tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults

Ortho Dermatologics Receives FDA Approval of Duobriitm (Halobetasol Propionate and Tazarotene) Lotion 0.01%/0.045% for Plaque Psoriasis in Adults First and Only Topical Lotion Combining Halobetasol Propionate and Tazarotene in One Formulation1 Safety was Established in a Long-Term Study of Up to 24 Weeks of Continuous Use and up to 52 Weeks of As-Needed Use2 RALEIGH, N.C., Apr. 25, 2019 – Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the...

Read More

IPC & IEC Joint Publication "Psoriasis and Atopic Dermatitis: Similiarities and Differences" - Now Available

A joint publication of the International Psoriasis Council & International Eczema Council "Psoriasis and Atopic Dermatitis: Similiarities and Differences" is Now Available on-line

Read More

Development of clinical diagnostic criteria for plaque psoriasis in children: An eDelphi consensus study with the International Psoriasis Council

An eDelphi study conducted by the University of Nottingham and the International Psoriasis Council identified of list of expert agreed diagnostic features the diagnosis of plaque psoriasis in children.

Read More

Biosimilars for Psoriasis - Experience from Europe

Biosimilars for Psoriasis - Experience from Europe Arnon D. Cohen, Tiago Torres, Wolf-Henning Boehncke, Menno de Rie, Denis Jullien, Luigi Naldi, Caitriona Ryan, Robert Strohal, Lone Skov, Peter van de Kerkhof, Joelle M. van der Walt, Jashin J. Wu, Claus Zachariae, Lluis Puig, Helen Young. Current Dermatology Reports (2019) 8:26–34 SUMMARY With increased use of biosimilars likely in the future, the IPC will continue to provide leadership, education, and guidance for dermatologists...

Read More

IPC 2018 Think Tank Miami Beach: A full program of scientific updates and future planning

The International Psoriasis Council (IPC) Think Tank was held at the Mondrian Hotel in Miami Beach, Florida, on November 30–December 1, where outside the air was warm, the music loud, and the clothing small, while, inside, the science sizzled and IPC councilors and invited guests engaged in a full program of scientific updates and future planning.

Read More

Swedish National Board of Health and Welfare present the first ever national guidelines for the treatment and care of psoriasis

The Swedish National Board of Health and Welfare have presented the first ever national guidelines for the treatment and care of psoriasis. Though there have been guidelines created for the treatment of psoriasis by different shareholders in the past, this is the first time the that guidelines have been published by the The National Board of Health and Welfare. Though current research has paved the way for new and effective treatments for psoriasis, the disease is still under-treated, and...

Read More

Now Available: 2018-2019 Global Psoriasis Atlas Annual Report

Global Psoriasis Atlas has released the annual report for April 2018- March 2019.

Read More

Long time IPC Councilor, Dr. Wayne Gulliver, awarded the Albert Neisser Lecture

Long time IPC councilor Dr. Wayne Gulliver has been awarded the 15th annual Albert Neisser Lecture.

Read More
UPCOMING EVENT

Hot topics and challenging cases in psoriasis: A focus on pustular, biosimilars, pediatrics and treating in under-served areas

Monday, june 10, 2019
1:30 – 4:30 pm
milan, italy
Register Now

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.
SUBSCRIBE

This website uses cookies. Please ensure your cookies are enabled. 
OK